- 902.424.8670
- info@innovacorp.ca
Coemergence Inc., a leading provider of software for enterprise intelligence management, was recently named one of the top competitive intelligence software providers in Fuld & Company’s 2008-2009 Intelligence Software Report.
Innovacorp president and CEO Dan MacDonald discusses the importance of creating and maintaining a strong culture of innovation in organizations.
THE 3M METHOD
CALLING ALL EXPORTERS
Coemergence, a leading provider of software for enterprise intelligence management used by the world’s most successful mining and resource companies, today announced Peter Hickey as its new president and CEO, effective immediately.
ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its vaccine platform.
Marcato Digital Solutions - Zone 5 winner and provincial finalist (2007-2008)
Zone 5 - Victoria, Cape Breton, Inverness and Richmond counties
CleanCount Inc. - Zone 2 winner and provincial finalist
Zone 2 - Lunenburg, Queens, Shelburne and Yarmouth counties
Click on the logos below to view four of the five I-3 Technology Start-Up Competition provincial finalist videos.
July 2008’s TecSocial at Cape Breton’s Membertou Trade & Convention Centre focused on student inventions. Attendees had the opportunity to learn about "The Amazing Alter-Leg" and the "Generator Backpack," innovations developed by local high school students.
The winner of Innovacorp's province-wide I-3 Technology Start-Up Competition, MorSwift Machines Inc., is featured in the summer edition of Nova Scotia Open to the World.
READ IT NOW. (Reproduced with permission from Progress Corp.)
Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy (NFIT) systems, and ImmunoVaccine Technologies, Inc. (IVT), a vaccine development company, today announced they have entered into a collaborative Research Agreement to assess utilization of the Biojector® 2000 for the delivery of IVT’s unique vaccine enhancement platform, DepoVaxTM.